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ORIGINAL RESEARCH

Comparison Between Different Strategies of Rheumatic Heart
Disease Echocardiographic Screening in Brazil: Data From the
PROVAR (Rheumatic Valve Disease Screening Program) Study
Bruno R. Nascimento, MD, MSc, PhD; Craig Sable, MD; Maria Carmo P. Nunes, MD, PhD; Adriana C. Diamantino, MD;
Kaciane K. B. Oliveira, MSc; Cassio M. Oliveira, PhD; Zilda Maria A. Meira, MD, PhD; Sandra Regina T. Castilho, MD, MSc;
Julia P. A. Santos, MD; Letıcia Maria M. Rabelo, MD; Karlla C. A. Lauriano, MD; Gabriel A. L. Carmo, MD, PhD; Allison Tompsett, MD;
Antonio Luiz P. Ribeiro, MD, PhD; Andrea Z. Beaton, MD; on behalf of the PROVAR (Rheumatic Valve Disease Screening Program)
Investigators*

Background-—Considering the limited accuracy of clinical examination for early diagnosis of rheumatic heart disease (RHD),
echocardiography has emerged as an important epidemiological tool. The ideal setting for screening is yet to be deﬁned. We aimed
to evaluate the prevalence and pattern of latent RHD in schoolchildren (aged 5–18 years) and to compare effectiveness of
screening between public schools, private schools, and primary care centers in Minas Gerais, Brazil.
Downloaded from http://jaha.ahajournals.org/ by guest on March 15, 2018

Methods and Results-—The PROVAR (Rheumatic Valve Disease Screening Program) study uses nonexperts and portable and
handheld devices for RHD echocardiographic screening, with remote interpretation by telemedicine, according to the 2012 World
Heart Federation criteria. Compliance with study consent and prevalence were compared between different screening settings, and
variables associated with RHD were analyzed. In 26 months, 12 048 students were screened in 52 public schools (n=10 901), 2
private schools (n=589), and 3 primary care centers (n=558). Median age was 12.9 years, and 55.4% were girls. Overall RHD
prevalence was 4.0% borderline (n=486) and 0.5% deﬁnite (n=63), with statistically similar rates between public schools (4.6%),
private schools (3.5%), and primary care centers (4.8%) (P=0.24). The percentage of informed consents signed was higher in
primary care centers (84.4%) and private schools (66.9%) compared with public schools (38.7%) (P<0.001). Prevalence was higher
in children ≥12 years (5.3% versus 3.1%; P<0.001) and girls (4.9% versus 4.0%; P=0.02). Only age (odds ratio, 1.12; 95% conﬁdence
interval, 1.09–1.17; P<0.001) was independently associated with RHD.
Conclusions-—RHD screening in primary care centers seems to achieve higher coverage rates. Prevalence among schoolchildren is
signiﬁcantly high, with rates higher than expected in private schools of high-income areas. These data are important for the
formulation of public policies to confront RHD. ( J Am Heart Assoc. 2018;7:e008039. DOI: 10.1161/JAHA.117.008039.)
Key Words: echocardiography • prevalence • rheumatic heart disease • screening • telemedicine

R

heumatic heart disease (RHD) is an important complication that affects patients after an acute rheumatic
fever episode.1 It accounts for the highest morbidity and
mortality among heart valve diseases worldwide, particularly

in middle- and low-income countries, and poses substantial
burden on health systems that struggle to meet the
demands.2 In 2015, the age-standardized prevalence of RHD
in endemic countries was 444/100 000 inhabitants,3 and the
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What Is New?
• Data from the ﬁrst large-scale Rheumatic Heart Disease
program in Brazil showed that integration of echocardiographic screening with the existing primary care system is
feasible and seems to achieve higher participation rates.
• Disease prevalence (both borderline and deﬁnite) among
schoolchildren in the southeastern state of Minas Gerais is
signiﬁcantly high in low-income areas, but rates higher than
expected were also observed in private schools located in
high-income neighborhoods.
• Among demographic and socioeconomic factors, age seems
to be the only variable independently associated with
echocardiographic prevalence, with a progressive pattern.

What Are the Clinical Implications?
Downloaded from http://jaha.ahajournals.org/ by guest on March 15, 2018

• These data are important for the formulation of public
policies and development of surveillance approaches to
confront rheumatic heart disease in high-prevalence
regions.
• The epidemiological features of streptococcal infections
may be more complex than anticipated in these areas, and
other factors besides socioeconomic status should be
further evaluated.
• Strategies tested in the PROVAR (Rheumatic Valve Disease
Screening Program) study, such as task shifting, computerbased training, use of portable and handheld affordable
devices, telemedicine for education purposes, and remote
diagnosis and diagonal integration with existing health
systems, may help overcome challenges for rheumatic
disease control programs in endemic areas.

inclusion of latent disease found in screening programs4–6
may increase this rate. Echocardiography is the most
sensitive screening tool for early detection of latent RHD,
identifying 10 times more subclinical disease when compared
with auscultation.7,8 In 2012, the World Heart Federation
published a consensus document with standardized echocardiographic criteria, and screening studies have followed them
since.9
RHD has been consistently associated with poor socioeconomic conditions, lower-income countries, and rural areas.
However, serological and bacteriological data about group A
streptococcal epidemiological features10–12 propose the
existence of geographical determinants, suggesting that
socioeconomic status may not be the unique factor. In Brazil,
an upper-middle income country still classiﬁed among the
most socially unequal in the world,13 the PROVAR (Rheumatic
Valve Disease Screening Program) study (the ﬁrst large-scale
screening program of the country) was implemented in
201414 and revealed an echocardiographic prevalence of
DOI: 10.1161/JAHA.117.008039

42/1000 in preliminary analyses. However, public schools of
underserved neighborhoods highlighted a marginal participation (<40%).15 Similar to other publications,16–18 this was
presumably related to the following: (1) lack of involvement by
authorities and schools’ representatives; (2) low parental
engagement, with poorest participation in areas with lowest
socioeconomic conditions; and (3) difﬁculties in monitoring
whether the consents were actually being delivered, because
parents are not present at the time of interaction.14,15 In
addition, difﬁculties related to simple procedures that affect
school routine signify that school screening may not be the
ideal approach.
The identiﬁcation of the most effective screening strategies is a crucial step for the incorporation of RHD detection as
a public policy in Brazil. To meet this goal, subsequent steps
of the program included integration of echocardiographic
screening within the primary care delivery system and
evaluation of children from high-income areas. In this study,
we aimed to evaluate the impact of these measures by
comparing the participation rate and prevalence and pattern
of latent RHD between public schools, private schools, and
primary care centers in school-aged children.

Methods
The data, analytic methods, and study materials will be made
available to other researchers for purposes of reproducing the
results or replicating the procedure, from the corresponding
author on reasonable request. The PROVAR study took place
between 2014 and 2017 in the state of Minas Gerais, southeast
Brazil. The study was conducted in the metropolitan areas of
Belo Horizonte (the capitol; 4.9 million inhabitants; mean
Human Development Index [HDI], 0.774; 92.9% coverage by
primary care) and Montes Claros (north of the state; 0.58 million inhabitants; mean HDI, 0.770; 99.1% coverage by primary
care), under the auspices of the Universidade Federal de Minas
Gerais and the Telehealth Network of Minas Gerais,19 in
collaboration with the Children’s National Health System
(Washington, DC). Ethics approval was obtained from the
institutional review boards of the participant institutions and
from the state and city Boards of Health and Education.
The method and the implementation of the PROVAR study
have been described elsewhere14,15: the study uses nonexperts for image acquisition, on portable (Vivid Q; GE
Healthcare, Milwaukee, WI) and/or handheld (Vscan; GE
Healthcare) devices for RHD echocardiographic screening,
and telemedicine interpretation by experts in Brazil and the
United States, according to the 2012 World Heart Federation9
criteria. The screening team consisted of 2 nurse research
coordinators (KO and CG), 1 biomedical technician, and 1
imaging technician (CO); during the preparatory phase, these
individuals underwent a combination of completing online
Journal of the American Heart Association
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Statistical Analysis
All data were systematically entered to the RedCap online
database.22 Statistical analysis was performed using SPSS
DOI: 10.1161/JAHA.117.008039

software, version 23.0, for Mac OSX (SPSS Inc, Chicago, IL).
Categorical variables, expressed as numbers and percentages, were compared between groups (public schools,
primary care centers, and private schools) using Fisher’s
exact test (with Bonferroni’s correction for multiple comparisons). Continuous data, expressed as meanSD or median
and quartile1/quartile3 (25%/75%), were compared using 1way ANOVA (and Student’s unpaired t test for pairwise
comparisons) or the Kruskal-Wallis test (and Mann-Whitney U
test for pairwise comparisons), as appropriate. Bivariate
logistic regression was used to look for individual predictors
of RHD (any RHD and deﬁnite cases, separately), and factors
that were signiﬁcant at P<0.10 were put into a multivariable
model. The variables evaluated were age (years), sex, number
of inhabitants per house, number of inhabitants aged
<15 years, screening setting, and the neighborhood’s HDI
(as a surrogate for socioeconomic status). When necessary,
transformations were done for analysis of variance. A 2-tailed
signiﬁcance level of 0.05 was considered statistically
signiﬁcant.

Results
The RHD educational curriculum was successfully delivered to
29 695 children, and 12 048 (40.6%) consented students
were enrolled in 52 public schools (Belo Horizonte, n=6353;
and Montes Claros, n=4548), 3 primary care centers (Montes
Claros, n=558), and 2 private schools (Belo Horizonte,
n=589). Of those from public schools, 5996 were enrolled
during the ﬁrst 14 months of the project, before the initiation
of the program in primary care centers and private schools.
The median age was 13.0 (quartile 1–3, 11.0–15.0) years,
55.4% were girls, and 55.4% were enrolled in the Belo
Horizonte metropolitan area. There were signiﬁcant differences between the groups on age, sex, number of inhabitants
per house, and HDI (Table 1).
In primary care, education (house-to-house and operative
groups) was successfully delivered to 270 families, from
which 661 children met the inclusion criteria and 84.4%
(n=558) were consented. In public and private schools, 38.7%
(10 901/28 168) and 66.9% (589/881) of eligible students,
respectively, undergoing the educational process returned the
signed informed consent (P<0.001). In public schools, overall
compliance improved from the ﬁrst 14 months (35.3%) to the
following 12 months of screening (42.9%) (P<0.001), and was
higher in the north (66.2%) compared with the capitol (29.5%)
(P<0.001) (Figure 1).
Overall RHD prevalence was 4.0% borderline (n=478) and
0.5% deﬁnite (n=63), with statistically similar rates between
public schools (4.0% and 0.6%, respectively), primary care
centers (4.2% and 0.7%, respectively), and private schools
(3.2% and 0.3%, respectively) (P=0.24). The prevalence of
Journal of the American Heart Association
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RHD educational modules and at least 6 weeks of hands-on
training.20
Public schools and primary care centers were enrolled
according to socioeconomic variables, following priorities of
health and education authorities, mostly based on low
socioeconomic indexes, considering the local HDI. Private
schools of high-income neighborhoods were randomly invited
to participate. An RHD educational curriculum was delivered
before screening in the following: (1) In public and private
schools, a school-wide educational process was provided to
all students, teachers, and school staff, involving slide
lectures on RHD basic concepts (replaced by a tablet-based
interactive module for 1400 random children), informative
brochures for family awareness, and explanatory letters.14
Informed consents were sent home with the students. (2) In
primary care, house-to-house education, with brochures and
letters, was provided to families by community health agents
during scheduled visits. Additional group education sessions
(so-called operative groups) were scheduled at the primary
care centers for children and families. Any person attending
the facility was also invited to participate. Informed consents
were actively collected during visits and group activities.
Any asymptomatic children whose parents provided written informed consent (mandatory according to Brazilian
regulations) answered a brief sociodemographic questionnaire
and underwent a simpliﬁed echocardiographic protocol
focusing on mitral and aortic valves. World Heart Federation
criteria9 were modiﬁed for handheld devices, in the absence
of spectral Doppler. Cloud computing environments, with
online reading for DICOM ﬁles and Dropbox with proprietary
ofﬂine software for Vscan ﬁles, were used for remote
telemedicine interpretation in Brazil and the United States.21
Readers were blinded to the screening scenario.
All screen-positive cases were blindly reviewed by 2
experts (M.N. and C.S.), and discrepancies were consensually
solved by a third blind reader (A.B.). Patients with conﬁrmed
echocardiographic abnormalities (borderline or deﬁnite RHD
and other abnormalities) were referred to the university
hospital for clinical and echocardiographic follow-up, and
continuing care was left to the discretion of the caring
pediatric cardiologist. In general, every 21 days, penicillin
injections were prescribed to all deﬁnite cases, and children
with borderline RHD were enrolled in scheduled medical
surveillance. Patients with other structural abnormalities were
also referred for specialized care (Figure 1). In this study, we
present data from 26 months (802 days) of the PROVAR
study, from October 2014 to December 2016.
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Figure 1. Flow chart of the PROVAR (Rheumatic Valve Disease Screening Program) study. CNHS
indicates Children’s National Health System; IRB, institutional review board; and UFMG, Universidade
Federal de Minas Gerais.

deﬁnite RHD was also similar between the different screening
settings (P=0.41) (Figure 2, Table 2). Among RHD screenpositive patients, median age was higher in private schools
(15.8 [quartile 1–3, 14.7–16.4] years) compared with public
schools (14.0 [quartile 1–3, 11.7–15.8] years) (P=0.005), but
similar to primary care centers (14.6 [quartile 1–3, 13.2–16.2]
years) (P=0.08). A total of 78 children (0.6%) had other
echocardiographic abnormalities not related to RHD; the most
prevalent were mitral valve prolapse (n=29), atrial septal
defects (n=10), bicuspid aortic valve (n=7), and ventricular
septal defects (n=3).

DOI: 10.1161/JAHA.117.008039

The pattern of valve disease is detailed in Table 2. In
patients with deﬁnite disease, 68.3% had mitral regurgitation
plus at least 2 morphological criteria of the mitral valve (100%
among children with deﬁnite RHD screened in primary care
centers and private schools), and 23.8% had mixed valve
disease. The World Heart Federation criteria for both borderline and deﬁnite RHD were statistically similar between
groups (Table 2). RHD prevalence was higher in children
≥12 years (5.3% versus 3.1%; P<0.001) and girls (4.9% versus
4.0%; P=0.02), and similar between the northern and central
regions (4.4% versus 4.5%; P=0.66). A progressive increase of

Journal of the American Heart Association
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Comparisons
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Variable

Public Schools (n=10 901)

Primary Care Centers (n=558)

Private Schools (n=589)

P Value

Age, median
(quartile 1–3)

12.8 (10.8–15.0)

13.7 (11.8–16.0)

15.7 (14.3–16.5)

<0.001

P<0.001*
P<0.001†
P<0.001‡

Age >12 y, N (%)

6510 (60.2)

397 (71.1)

544 (93.6)

<0.001

P<0.001*
P<0.001†
P<0.001‡

Male sex, N (%)

4845 (44.8)

267 (47.9)

224 (38.1)

0.002

P=0.16*
P=0.001†
P=0.001‡

No. of inhabitants,
median (quartile 1–3)

4.0 (4.0–5.0)

4.0 (4.0–5.0)

4.0 (3.0–4.0)

<0.001

P=0.65*
P<0.001†
P<0.001‡

No. of inhabitants <15 y,
median (quartile 1–3)

2.0 (1.0–2.0)

1.0 (1.0–2.0)

1.0 (0–2.0)

<0.001

P<0.001*
P<0.001†
P<0.001‡

HDI, median
(quartile 1–3)

0.770 (0.762–0.801)

0.770 (0.770–0.770)

0.955 (0.955–0.955)

<0.001

P=0.38*
P<0.001†
P<0.001‡

HDI indicates Human Development Index; and quartile 1–3, 25%–75%.
*Public schools vs primary care.
†
Public schools vs private schools.
‡
Primary care vs private schools.

RHD (borderline and deﬁnite) with age was observed, reaching
6.0% in children aged ≥14 years.
In the bivariate regression analyses, age (odds ratio [OR],
1.13), female sex (OR, 1.24), and number of inhabitants aged
<15 years in the household (OR, 0.89) were associated with
the presence of any RHD, and age (OR, 1.22) was the only
variable associated with deﬁnite disease. In multivariable
analysis, age (OR, 1.12) was the only predictor of any RHD,
with a borderline signiﬁcance observed for sex. There was no
association between the different screening settings and the
prevalence observed (Table 3).

Discussion
The data from >12 000 children screened in 26 months of
the PROVAR study (the ﬁrst large-scale screening program in
Brazil) highlight the much better screening coverage observed
in primary care centers and private schools (84% and 67%,
respectively, in contrast with 39% in public schools). Findings
also show the high prevalence of RHD echocardiographic
ﬁndings in this region of the country, with surprising similar
rates and pattern of disease between the 3 study settings,
contrasting with previously published data from other
regions.16,18,23 These data reinforce the need for diagonal
integration of RHD control with the existing health system.
DOI: 10.1161/JAHA.117.008039

The high overall prevalence of RHD reinforces the preliminary ﬁndings of the PROVAR study,15 and again helps explain
the great burden of severe late valvular sequelae, leading to
interventions and posing great costs to the Brazilian public
health system (SUS).24 Despite these observations, no
integrating national programs or public policies for disease
surveillance,
as
recommended
by
international
documents,25,26 have been implemented in the past decades.
Notwithstanding the existing administrative SUS database,
the paucity of consistent data on the efﬁcacy and costeffectiveness of different preventive strategies may be among
the reasons for that. The limitations of the databases
(noticeably, the absence of speciﬁc codes for RHD in surgical
procedures) along with the nonincorporation of subclinical
disease and the lack of different models for speciﬁc
population subsets (eg, teenagers versus adults) may explain
the underestimation of RHD prevalence in Brazil and Latin
America in the Global Burden of Disease study.3 To develop
adequate public health policies and lower the impact of RHD,
it is key to target higher-risk populations with the most
comprehensive approach possible, to diagnose early-stage
disease and initiate secondary prophylaxis to prevent
progression.27
RHD prevalence in private schools situated in high-income
areas of Belo Horizonte was greater than anticipated. This
Journal of the American Heart Association
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Table 1. Demographic and Clinical Characteristics of Children Undergoing Echocardiographic Screening in Public Schools, Primary
Care Centers, and Private Schools
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Figure 2. Echocardiographic prevalence of rheumatic heart disease according to screening location:
public schools, primary care centers, and private schools.

ﬁnding contrasts with ﬁndings of previously published
studies,16,18 and we speculate about the contribution of
several factors. First, the prevalence of group A streptococcus among children presenting with acute pharyngotonsillitis
in Brazil seems to be higher than in other developing
countries,28,29 possibly as a result of a complex interaction
between climatic factors, behavioral patterns, and genetic
predisposition. Previous studies have also demonstrated that
factors related with RHD onset, such as persistently elevated
anti–streptolysin O titers, are not necessarily paralleled with
socioeconomic status.10 Moreover, it is suggested that some
group A streptococcal emm clusters may have a tropism for
deﬁned geographical areas,11,12 besides their social determinants. These ﬁndings highlight the complex nature of group A
streptococcal epidemiological features. Second, despite the
wider access of families with private insurance to specialized
health care in Brazil, primary care and health promotion
initiatives are still scarce in this setting, which may affect
primary prevention. Third, there is no geographical circumscription for private schools in Brazil, as there is for public
education, and children from different areas share the same
institutions. Thus, despite the high costs of these schools,
the demographic and socioeconomic strata may not reﬂect
those of the regions where the schools are located. Fourth,
the higher median age and the greater proportion of girls in
private schools may have overestimated prevalence. However, further studies are needed to know if this trend is real
DOI: 10.1161/JAHA.117.008039

and to determine the driving factors behind the higher than
expected prevalence in these middle- to high-income children, because systematic data from other developing countries are scarce.
Our data point toward low compliance with study consent in
public schools, in contrast with the high rates in primary care
centers and private schools, although sample size was limited
in the last 2 locations. Besides the previously recognized
factors (mainly related to suboptimal involvement of school
representatives and staff and to involvement of parents14), the
low coverage in public schools is also attributed to some
particularities of Brazilian health regulations. First, nonphysicians are not allowed to acquire echocardiographic images
outside research protocols or to make ofﬁcial diagnoses. Thus,
informed consents are mandatory for such procedures. However, in resource-limited health systems, like the Brazilian SUS,
task shifting has proved to be a crucial tool to improve
availability and reduce costs of screening, freeing high-level
personnel for more complex tasks.27 The efﬁcacy of nurses,
technicians, and other professionals in performing simpliﬁed
protocols has been demonstrated, as has their accuracy for
identifying positive cases, even in simpliﬁed protocols and with
limited training.20,30–32 Second, individual consents (and not
collective consents) are required for any research procedure.
This poses a signiﬁcant burden for school-based programs
while RHD screening is not incorporated as part of regular
health care, and favors the primary care strategy.
Journal of the American Heart Association
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Table 2. Prevalence of RHD Echocardiographic Findings and WHF Criteria for Borderline and Deﬁnite Disease in Children
Undergoing Screening in Public Schools, Primary Care Centers, and Private Schools

Variable

Public Schools
(n=10 901)

Primary Care
Centers (n=558)

Private
Schools (n=589)

P Value*

Borderline RHD, N (% [95% CI])

433 (4.0 [3.8–4.6])

26 (4.7 [3.4–7.2])

19 (3.2 [2.2–5.2])

0.46

Definite RHD, N (% [95% CI])

60 (0.6 [0.5–0.8])

1 (0.2 [0.0–1.0])

2 (0.3 [0.1–1.2])

0.41

Other, N (% [95% CI])

65 (0.6 [0.5–0.8])

6 (1.1 [0.5–2.3])

7 (1.2 [0.6–2.4])

0.10

A. At least 2 morphological features
of RHD of the MV without pathological
MR or MS

15 (3.5)

1 (3.8)

0

0.35

B. Pathological MR

360 (83.1)

18 (69.2)

16 (84.2)

C. Pathological AR

58 (13.4)

7 (26.9)

3 (15.8)

40 (66.7)

1 (100)

2 (100)

WHF criteria for borderline RHD, N (%)

WHF criteria for definite RHD, N (%)
A. Pathological MR and at least 2
morphological features of RHD of the MV
Downloaded from http://jaha.ahajournals.org/ by guest on March 15, 2018

B. MS mean gradient >4 mm Hg

0

0

0

C. Pathological AR and at least 2 morphological
features of RHD of the AV

5 (8.3)

0

0

D. Borderline disease of both the AV and MV

15 (25.0)

0

0

0.83

AR indicates aortic regurgitation; AV, aortic valve; CI, conﬁdence interval; MR, mitral regurgitation; MS, mitral stenosis; MV, mitral valve; RHD, rheumatic heart disease; and WHF, World
Heart Federation.
*Fisher’s exact test was used for multiple comparisons of proportions between groups.

A signiﬁcant innovation of Brazilian public health was the
implementation of the SUS in the 1990s, with a rapid scaling
up of a community approach to deliver primary care through

community health agents (members of the population hired by
the health system) responsible for a deﬁned population or
area. The close contact favors health promotion and allows a

Table 3. Factors Associated With the Presence of Echocardiographic Findings of RHD (Any or Deﬁnite): Bivariate and Multivariate
Analyses
Diagnosis

Any RHD (n=541)

Variable

OR (95% CI)

P Value

OR (95% CI)

P Value

Age (each 1 y)

1.13 (1.10–1.16)

<0.001*

1.22 (1.11–1.34)

<0.001*

Sex (female)

1.24 (1.04–1.48)

0.016*

1.37 (0.82–2.30)

0.23

No. of inhabitants

0.99 (0.94–1.05)

0.79

1.05 (0.91–1.21)

0.54

No. of inhabitants <15 y

0.89 (0.82–0.97)

0.007*

0.85 (0.66–1.09)

0.20

1.09 (0.80–1.47)

0.60

2.11 (0.66–6.74)

0.21

Screening in public schools

†

Screening in primary care centers

†

Deﬁnite RHD (n=63)

1.09 (0.73–1.61)

0.68

0.33 (0.05–2.39)

0.27

Screening in private schools†

0.78 (0.50–1.21)

0.29

0.64 (0.16–2.61)

0.53

HDI

1.12 (0.34–3.69)

0.85

0.79 (0.03–24.5)

0.89

Age (each 1 y)

1.12 (1.09–1.17)

<0.001*





Sex (female)

1.18 (0.98–1.42)

0.09





No. of inhabitants <15 y

1.01 (0.93–1.10)

0.84





Multivariable analysis

CI indicates conﬁdence interval; HDI, Human Development Index; OR, odds ratio; and RHD, rheumatic heart disease.
*P<0.05.
†
Three models were run for the bivariate analysis.
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Table 4. Adaptable Strategies for Successful Active RHD Surveillance
PROVAR Design Feature

Challenge Addressed

Translational Strategy for LMIC

Screening for RHD within
primary healthcare clinics

Vertical (RHD-specific) vs diagonal (integration into
existing systems) program

Identification of platforms for accessing at-risk
populations (women and children)
Integration with other disease-specific programs
or primary care (when available)

Follow-up of screen-positive
cases at the primary healthcare
center

Low rates of follow-up for screen+examinations,
patient barriers
to travel for care

Consider outreach strategies to bring follow-up
locally, task shifting to lower providers after
initial confirmatory diagnosis

Use of handheld echocardiography
machines

Equipment costs, multifunctional uses

Consider point-of-care (not fully functional)
echocardiographic equipment to reduce costs,
and equipment that can be multipurpose
(obstetrical and vascular imaging)

Use of equipment for all cardiac
concerns and all ages

Single focus (RHD) vs assessment for other common
cardiac conditions
Improved overall care delivery

Explore expansion of indications for screening
echocardiography to address other cardiac
conditions

Educational programs for community
awareness (house-to-house education
by community health workers already
visiting homes)

Suboptimal participation in screening. Low community
knowledge of RHD

Identification of existing educational resources
(village health teams, schools, and community
organizations) to add RHD education

Use of nonspecialty physicians and
nonphysicians for image acquisition

Constrained human resources

Identify a workforce available for continuous
training of nonexperts, task shift as appropriate

Web-based initial training

Trainer and trainee time, need for ongoing training
of new staff

Consider asynchronous learning platforms

Telemedicine for diagnosis

Constrained human resources, large geographic areas

Consider best staffing for final diagnosis in
your setting
Can experts be virtually accessed thorough
telemedicine

Continuous competency assessment

Maintenance of high standards and competency

Consider remote monitoring and retraining
of staff through telemedicine

Web-based RHD registry

Case tracking and provision of secondary prophylaxis

Consider centralized registers, making RHD
a reportable condition

Diagonal integration

Downloaded from http://jaha.ahajournals.org/ by guest on March 15, 2018

Task shifting

Telemedicine/web-based applications

LMIC indicates low- and middle-income countries; PROVAR, Rheumatic Valve Disease Screening Program; and RHD, rheumatic heart disease.

deep integration between community needs and the health
system, facilitating preventive interventions.33 Integration of
echocardiography screening strategies with the existing SUS
may be a future direction and has been successfully evaluated
in different settings. Even in high-resourced regions, like the
United Kingdom, population-based echocardiographic screening of asymptomatic elderly individuals was feasible, and the
presence of valve disease was associated with socioeconomic
status.34 In low-income areas, such as India, a mass screening
strategy in rural areas with focused handheld echocardiography performed by nonexperts and remote interpretation,
similar to the PROVAR study ﬂow chart, was also successful
and revealed an alarming 16% of major echocardiographic
abnormalities (32.9% valve disease), with an important
contribution of RHD.35

DOI: 10.1161/JAHA.117.008039

Telemedicine has been successfully applied since the
beginning of the PROVAR study. The project has collaborated
with the development of cloud storage and reading systems
dedicated to cardiovascular imaging and used a collaborative
reading routine between Brazil and the United States, an
innovation for large-scale RHD programs.21 The incorporation
of the RHD project was also an improvement for the Telehealth
Network of Minas Gerais. The network was established in
2005 to connect hospitals from 5 public universities in the
state. Since then, it has been successfully delivering health
care to remote and underserved areas, providing costeffective36 services (teleelectrocardiography, teleconsultations,19 diabetes mellitus care,37 and support to systems of
care) that give support to primary care through a network of
experts. RHD programs can beneﬁt from the existing
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Limitations
Our study has several limitations, especially related to the lack
of association between socioeconomic variables and RHD
prevalence. First, the HDI estimation has some inaccuracies:
some northern municipalities have estimates for large areas,
and not for speciﬁc locations and neighborhoods (eg, Montes
Claros metropolitan area). It is also common that public
schools enroll children from geographically related areas with
discrepant socioeconomic conditions. Also, even private
schools in the capitol, with their considerable costs, are
usually a reference for children from different regions of the
state, sometimes with different sociodemographic backgrounds. Second, despite the multiple engagement strategies
applied by the PROVAR study (markedly, the multiple educational strategies14,15), student participation in public schools
remained marginal, which may bias prevalence estimates. This
contrasts with the higher coverage in the primary care setting,
reinforcing the need for diagonal integration. Third, because
the PROVAR study was primarily designed for public schools,
the smaller sample size in primary care centers and private
schools may have underpowered the analysis to access the
differences in prevalence, especially for the latter. Fourth, all
consented children were consecutively included, without
stratiﬁed sampling procedures, increasing the risk of bias
associated with differences between groups (eg, higher
median age in private schools). Fifth, because follow-up
conﬁrmatory echocardiograms were not considered,
DOI: 10.1161/JAHA.117.008039

prevalence estimates may be biased upward, especially for
handheld devices.20 Last, the study was conducted in 2
metropolitan areas of the state of Minas Gerais, and the
ﬁndings cannot be directly extrapolated to the entire country.
Despite these limitations, the importance of the PROVAR study
for the development of public policies is undoubtable, as the
biggest RHD screening data in Latin America to date and the
most reliable estimates for the Brazilian territory.

Conclusions
Our data show that the echocardiographic prevalence of RHD
among schoolchildren from the Brazilian southeastern state of
Minas Gerais is signiﬁcantly high, especially in public schools,
but with rates higher than expected in private schools of highincome areas. Screening in primary care seems to achieve
signiﬁcantly higher participation rates. These data are important for the formulation of public policies and development of
diagnostic approaches to confront RHD in high prevalence
regions.

Appendix
PROVAR (Rheumatic Valve Disease Screening
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Verizon supported and funded the rheumatic heart disease
(RHD) screening program in Brazil, General Electric Healthcare
provided echocardiography equipment, Vitel Net collaborated
and contributed to the development of the RHD cloud
platform, and Edwards Lifesciences funds the ongoing phases
of the primary care screening program. The Telehealth
Network of Minas Gerais was funded by the State Government of Minas Gerais, by its Health Department (Secretaria de
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infrastructure, political support, community involvement, and
adaptation to local work routines for integration with primary
care.19 Telemedicine and several adaptable strategies of the
surveillance model applied by the PROVAR study can intersect
with RHD programs of underserved regions and contribute to
overcome challenges, as depicted in Table 4.
In summary, although the study was conducted in a single
state, the PROVAR study data bring some aspects of RHD
control in Brazil to discussion: (1) evaluation of populations of
higher social strata should be considered, because socioeconomic variables may not be the only determinants of the
disease; (2) a combined strategy, with a school-based
approach and integration with the existing SUS, may improve
coverage and efﬁcacy of screening; (3) the high burden of
disease (both subclinical and advanced) urges the incorporation of some recommendations of international documents on
RHD control.26 These recommendations may include the
development of prospective RHD registers, maintenance of
adequate benzathine penicillin supplies, decentralization of
technical expertise, establishment of excellence centers for
integrated national control programs, and structuring of
partnerships with different sectors of society, with the
common goal of ﬁghting RHD.
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